Navigation Links
Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis
Date:3/5/2008

Preclinical profile and potential for lower cardiac toxicity drives

investigator interest

SEATTLE, March 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that its investigational drug pixantrone will be studied in a multicenter phase I/II trial initiated by the Fondation Charcot Stichting, in Brussels, Belgium, which sponsors a consortium of centers involved in studying new therapies for the treatment for multiple sclerosis. This study will enroll patients with aggressive relapsing remitting (RR) or secondary progressive (SP) multiple sclerosis (MS). Mitoxantrone, a related compound which is less active in preclinical studies, has been approved by the U.S. Food and Drug Administration (FDA) for the reduction of neurological disability and/or frequency of clinical response in patients with SP MS. A phase III trial with pixantrone in relapsed aggressive non-Hodgkin's lymphoma (NHL) is near completion.

"Despite the availability of newer biologic agents, drugs such as mitoxantrone remain an important therapy in relapsing MS. Long term cardiotoxicity remains a major drawback to treating multiple sclerosis with mitoxantrone and imposes a limitation both for selection of patients and for the duration of the treatment," said R.E. Gonsette, M.D., Chairman Fondation Charcot Stichting and principal investigator of the study. "In addition to the potential for lower cardiac toxicity, preclinical studies suggest that pixantrone may provide more effective immune regulation than mitoxantrone, the only currently approved cytotoxic agent for treating MS."

The investigator-sponsored trial (IST) will enroll 20 patients in Belgium, France and Germany.

About the Study

Twenty patients with aggressive RR MS or SP MS who failed to respond to approved immunomodulatory agents (interferons, glatiramer acetate) will be included. The objectives of the study are to determine the
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
3. Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
7. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
10. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
11. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... HILL, Conn. , July 2, 2015 ... Chief Executive Officer announced that Tamas Feitel ... Feitel joins Numotion after a highly successful 18 ... finance leadership roles driving strategy, profitability, and productivity to ... His most recent position was Chief Financial Officer for ...
(Date:7/2/2015)... N.C. , July 2, 2015 ... assets related to the ion channel biology platform from ... been obtained as part of Pfizer,s 2011 acquisition of ... rights to the "Icagen" name and trademark.  XRPro Sciences ... services for ion channel and transporter drug discovery, combining ...
(Date:7/2/2015)...  Konica Minolta, Inc. (Konica Minolta) ( Tokyo ... Sawae Technologica Ltda., an X-ray system equipment manufacturer based ... its Brazilian healthcare sales company, Konica Minolta Healthcare do ... Brazil market investment and growth With ... million, significant healthcare technical advancements and efficiencies are required. ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... Androgen Deprivation and, Chemotherapy Reduced Size of Formerly Resistant Tumors ... Confirm Bavituximab,s Potential to Enhance Multiple ... Combination Regimens for Cancer Therapy -, ATLANTA, and TUSTIN, ... a clinical stage,biopharmaceutical company developing targeted monoclonal antibodies for the,treatment ...
... to More Effective Antibiotics Against ,Superbugs, BOSTON, ... of Engineering may have discovered the path,toward developing ... have developed resistance to common antibiotics. The,researchers have ... bacteria that opens to door to new avenues ...
Cached Medicine Technology:Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 2Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 3Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 4Boston University Biomedical Engineers Find Chink in Bacteria's Armor 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 3
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness and ... they provide members of the Red Deer community with free fitness training and indoor ... training, games, food, events and entertainment raised thousands of charity dollars and ended with ...
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... store located in the Lone Star State. The premium frozen yogurt chain was listed ... The store, which opened July 1 at Duke’s Travel Plaza, is located at:, 30176 ...
(Date:7/2/2015)... RI (PRWEB) , ... July 02, 2015 , ... Many ... safety in mind. That’s why Amica Insurance is sharing some tips to ... Commission (CPSC), approximately 230 people go to the emergency room daily with fireworks-related injuries ...
(Date:7/2/2015)... ... , ... As Americans celebrate the Fourth of July outdoors this weekend, local ... rise. July is UV Safety Month, and physicians at American Family Care and AFC ... checks. Experts say most skin cancers can be found early with regular skin exams. ...
(Date:7/2/2015)... ... ... The ZAC Foundation, a national leader in water safety education and drowning ... stay water safe with the help of a young polar bear named Zeke. ... follows Zeke’s water safety journey. Zeke, who is afraid of the water and ...
Breaking Medicine News(10 mins):Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3
... 3 million residents of Georgia, U.S has been reported missing. ... , The CD is said to contain social security ... in Medicaid or PeachCare, a state health insurance program for ... , Affiliated Computer Services (ACS), a Dallas company that handles ...
... that not only do heavy women smokers have a ... run// the risk of their unborn male fetuses ... , The study authors from the Liverpool School of Tropical ... third less likely to give birth to boys than non-smokers. ...
... by the World Health Organization has reiterated the earlier ... stroke, with excessive consumption salt. The report has impressed ... the consumption of sodium to 2,000 milligrams per day, ... ,Since 1978, CSPI has been pressurizing the U.S. Food ...
... Health & Family Welfare has proposed amendment to the ... cosmetic products for the purpose of their import into ... has been published inviting objections and suggestions from the ... Government. The comments, if any, should be addressed to ...
... water per person in India will drop by almost 38 ... // ,According to the fourth assessment report of the ... availability in the country will decline from 1,820 cubic meters ... ,"The water availability in the county would reduce by almost ...
... wave with day temperatures in state capital Raipur and ... to 42 degrees Celsius. ,Roads wore a ... Raipur, people preferred to remain indoors while government offices ... forecast a further rise in heat this week with ...
Cached Medicine News:Health News:Sons Gone Up In Smoke 2Health News:India's Water Availability Will Decline by 2050 2
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
MBP's 200 L large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
... The assay is an immunometric ... of LH in human serum or ... bound by 2 monoclonal anti-LH antibodies ... is attached to magnetic particles and ...
... hormone (LH) is a glycoprotein secreted by ... hCG and TSH, the intact LH molecule ... beta-subunits. These glycoproteins all have homologous alpha-subunits, ... Both LH and FSH production and secretion ...
Medicine Products: